Article
Spinal cord and brain concentrations of riluzole after oral and intrathecal…
medRxiv · 2022 · Keifer, O.; Gutierrez Gonzalez, J.; Butt, M.; Cramer, S.; Bartus, R.; Tansey, M.; Deaver, D.; Betourne, A.; Boulis, N.
Key facts
| Title | Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: a potential new treatment route for amyotrophic lateral sclerosis |
|---|---|
| First author | Keifer, O.; Gutierrez Gonzalez, J.; Butt, M.; Cramer, S.; Bartus, R.; Tansey, M.; Deaver, D.; Betourne, A.; Boulis, N. |
| Journal | medRxiv |
| Published | Nov 3, 2022 |
| DOI | 10.1101/2022.11.02.514962 |
| Devices mentioned | K121908, K151991, K800178, K870782, K931338, K943773, K982541, P860004, P860004S028, P860004S029, P860004S030, P860004S054 and 16 more |
| Product codes mentioned | DTL, DWE, FDE, FMH, FMI, FPA, HGI, HXX, KDD, LGW, LKK, LRO and 18 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1